EP3310371
Glúkagon og GLP-1 sam-örva efnasambönd
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
16.6.2016EP published:
30.9.2020EP application number:
16733268.3
EP translation filed:
27.10.2020Grant published:
15.11.2020EPO information:
European Patent Register
Max expiry date:
15.6.2036Expiry date:
15.6.2026Next due date:
30.6.2026
Title:
GLUCAGON AND GLP-1 CO-AGONIST COMPOUNDS
Timeline
Today
16.6.2016EP application
30.9.2020EP Publication
27.10.2020Translation submitted
15.11.2020Registration published
15.6.2026Expires
Owner
Name:
Eli Lilly and CompanyAddress:
Lilly Corporate Center, Indianapolis, IN 46285, US
Inventor
Name:
CHEN, YanyunAddress:
Indianapolis, Indiana 46206-6288, US
Name:
MEZO, Adam RobertAddress:
Indianapolis, Indiana 46206-6288, US
Name:
QU, HongchangAddress:
Indianapolis, Indiana 46206-6288, US
Name:
VALENZUELA, Francisco AlcidesAddress:
Indianapolis, Indiana 46206-6288, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201562182847 PDate:
22.6.2015Country:
US
Classification
Categories:
A61K 38/00, A61K 38/26, C07K 14/605, C07K 14/00, A61P 3/00, A61P 1/00
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 19.5.2021
Expires: 15.6.2022
Payer: Patice ehf.
Number: 7
Paid: 18.5.2022
Expires: 15.6.2023
Payer: Patice ehf.
Number: 8
Paid: 24.5.2023
Expires: 15.6.2024
Payer: Árnason Faktor ehf.
Number: 9
Paid: 21.5.2024
Expires: 15.6.2025
Payer: Árnason Faktor ehf.
Number: 10
Paid: 10.6.2025
Expires: 15.6.2026
Payer: Árnason Faktor ehf.